Medicare Part D

FILE - In this June 14, 2011, file photo, various prescription drugs on the automated pharmacy assembly line at Medco Health Solutions in Willingboro, N.J. Medicare recipients cut back on pricey brand-name drugs but they still had to spend more on such medications anyway, according to a government report that blames rising manufacturer prices for squeezing older people and taxpayers. (AP Photo/Matt Rourke, File)
June 04, 2018 - 6:10 am
WASHINGTON (AP) — Medicare recipients filled fewer prescriptions for pricey brand-name drugs — but spent more on such meds anyway, says a government report due out Monday. It blames rising manufacturer prices for squeezing older people and taxpayers. The Health and Human Services inspector general'...
Read More
FILE - In this June 14, 2011, file photo, various prescription drugs on the automated pharmacy assembly line at Medco Health Solutions in Willingboro, N.J. Medicare recipients cut back on pricey brand-name drugs but they still had to spend more on such medications anyway, according to a government report that blames rising manufacturer prices for squeezing older people and taxpayers. (AP Photo/Matt Rourke, File)
June 04, 2018 - 12:59 am
WASHINGTON (AP) — Medicare recipients filled fewer prescriptions for pricey brand-name drugs — but spent more on such meds anyway, says a government report due out Monday. It blames rising manufacturer prices for squeezing older people and taxpayers. The Health and Human Services inspector general'...
Read More
FILE - In this June 14, 2011, file photo, various prescription drugs on the automated pharmacy assembly line at Medco Health Solutions in Willingboro, N.J. Medicare recipients cut back on pricey brand-name drugs but they still had to spend more on such medications anyway, according to a government report that blames rising manufacturer prices for squeezing older people and taxpayers. (AP Photo/Matt Rourke, File)
June 04, 2018 - 12:57 am
WASHINGTON (AP) — A new government report says Medicare recipients filled fewer prescriptions for pricey brand-name drugs — but spent more on such meds anyway. The Health and Human Services inspector general's office blames rising manufacturer prices for squeezing older people and taxpayers alike...
Read More
President Donald Trump speaks during an event about prescription drug prices with Health and Human Services Secretary Alex Azar, left, in the Rose Garden of the White House in Washington, Friday, May 11, 2018. (AP Photo/Carolyn Kaster)
May 12, 2018 - 12:45 am
WASHINGTON (AP) — President Donald Trump's long-promised plan to bring down drug prices would mostly spare the pharmaceutical industry he previously accused of "getting away with murder." Instead he focuses on private competition and more openness to reduce America's prescription pain. In Rose...
Read More
President Donald Trump speaks during an event about prescription drug prices with Health and Human Services Secretary Alex Azar, left, in the Rose Garden of the White House in Washington, Friday, May 11, 2018. (AP Photo/Carolyn Kaster)
May 11, 2018 - 10:41 pm
WASHINGTON (AP) — President Donald Trump's long-promised plan to bring down drug prices, unveiled Friday, would mostly spare the pharmaceutical industry he previously accused of "getting away with murder." Instead he focuses on private competition and more openness to reduce America's prescription...
Read More
President Donald Trump speaks during an event about prescription drug prices with Health and Human Services Secretary Alex Azar, left, in the Rose Garden of the White House in Washington, Friday, May 11, 2018. (AP Photo/Carolyn Kaster)
May 11, 2018 - 6:40 pm
WASHINGTON (AP) — President Donald Trump's long-promised plan to bring down drug prices, unveiled Friday, would mostly spare the pharmaceutical industry he previously accused of "getting away with murder." Instead he focuses on private competition and more openness to reduce America's prescription...
Read More
FILE - In this Jan. 10, 2018, file photo Sen. Ron Wyden, D-Ore., speaks at the Capitol in Washington. Some Medicare beneficiaries would face higher prescription drug costs under President Donald Trump’s budget even as the sickest patients save money. That may make it harder to sell the complex plan to Congress in an election year. (AP Photo/J. Scott Applewhite, File)
February 13, 2018 - 4:37 pm
WASHINGTON (AP) — Some Medicare beneficiaries would face higher prescription drug costs under President Donald Trump's budget even as the sickest patients save thousands of dollars, a complex trade-off that may make it harder to sell Congress on the plan in an election year. In budget documents,...
Read More
FILE - In this Jan. 10, 2018, file photo Sen. Ron Wyden, D-Ore., speaks at the Capitol in Washington. Some Medicare beneficiaries would face higher prescription drug costs under President Donald Trump’s budget even as the sickest patients save money. That may make it harder to sell the complex plan to Congress in an election year. (AP Photo/J. Scott Applewhite, File)
February 13, 2018 - 3:19 pm
WASHINGTON (AP) — Some Medicare beneficiaries would face higher prescription drug costs under President Donald Trump's budget even as the sickest patients save thousands of dollars, a complex trade-off that may make it harder to sell Congress on the plan in an election year. In budget documents,...
Read More
FILE - In this Sept. 1, 2004, file photo, medical bottles bearing tracking codes in the McKesson medical distribution center in Delran, N.J. President Donald Trump has made big promises to reduce prescription drug costs, but his administration is gravitating to relatively modest steps such as letting Medicare patients share in manufacturer rebates. (AP Photo/Brian Branch-Price, File)
February 12, 2018 - 12:33 am
WASHINGTON (AP) — President Donald Trump makes big promises to reduce prescription drug costs, but his administration is gravitating to relatively modest steps such as letting Medicare patients share in manufacturer rebates. Those ideas would represent tangible change and they have a realistic...
Read More
FILE - In this Sept. 1, 2004, file photo, medical bottles bearing tracking codes in the McKesson medical distribution center in Delran, N.J. President Donald Trump has made big promises to reduce prescription drug costs, but his administration is gravitating to relatively modest steps such as letting Medicare patients share in manufacturer rebates. (AP Photo/Brian Branch-Price, File)
February 10, 2018 - 4:17 pm
WASHINGTON (AP) — President Donald Trump makes big promises to reduce prescription drug costs, but his administration is gravitating to relatively modest steps such as letting Medicare patients share in manufacturer rebates. Those ideas would represent tangible change and they have a realistic...
Read More

Pages